Local: Los Angeles, CA  (change)

 | 

Join the Topix community today: 

Sign Up

 | 

Sign In

Advertisment
Biotech

Monday Jul 21

New HIV treatments slash into sales of Trimeris' Fuzeon

Global sales of Trimeris ' HIV drug, Fuzeon, dropped 38 percent in the second quarter, data released Monday say.

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Biotech Discussions
Topic Updated Last By Comments
First payments in Vioxx deal to begin Aug. 28 3 hr MIKE C 3
Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) 3 hr MIKE C 66
Long-term plan may help cure what ails Merck stock 5 hr rhonda 1
ADVANTAGE: Who was actually in charge of R&D? A... 5 hr rhonda 1
Researchers: Merck Vioxx study was for marketing 5 hr rhonda 1
Merck - Vioxx: a spoonful of sugar 5 hr rhonda 1
Merck to fund Vioxx settlement in August 5 hr rhonda 21